At the molecular level, 5-amino-1MQ functions as a competitive inhibitor of NNMT, demonstrating remarkable potency with an IC of 1.2 0.1 M under standard assay conditions (50 M SAM, 100 M nicotinic acid). This represents a dramatic 10-fold improvement over the parent compound 1-methylquinolinium, achieved through strategic amino group substitution that enhances binding affinity to the NNMT active site. The compound's mechanism centers on preventing the methylation of nicotinamide to 1-methylnicotinamide (1-MNA), thereby preserving nicotinamide for recycling back to NAD+ through the salvage pathway. This intervention effectively blocks what researchers have termed the "NNMT metabolic drain" a process that simultaneously depletes NAD+ precursors and consumes cellular methylation capacity
comparative effectiveness and safety of bariatric procedures for weight loss: a PCORnet cohort study
FAQs Can I inject bacteriostatic water on its own
Current cancer drug targets, 22 (9), 717724
Alt Text: GHK-Cu peptide regulatory context map showing cosmetic, compounding, injectable safety, and approved drug label distinctions
In the case of SP used to promote bone healing and regeneration, most of them have only been evaluated in vitro or in preclinical animal studies
